Asthma biomarkers and COVID-19 continue to dominate current medical issues
- PMID: 36065102
- PMCID: PMC9465642
- DOI: 10.2500/aap.2022.43.220062
Asthma biomarkers and COVID-19 continue to dominate current medical issues
References
-
- Khan NS, Rubin E, McKenna B, et al. Biomarker underuse contributes to an inability to phenotype patients with severe uncontrolled asthma. Allergy Asthma Proc. 2022; 43:383–387. - PubMed
-
- Mamyrbekova SM, Iskakova G, Faizullina K, et al. The diagnostic accuracy of spirometry versus peak expiratory flow test for follow-up of adult asthma patients at primary care level. Allergy Asthma Proc. 2022; 43:e58–e64. - PubMed
-
- Sengul Emeksiz Z, Yılmaz D, Alan B, et al. Clinical utility of serum tryptase levels in pediatric anaphylaxis. Allergy Asthma Proc. 2022; 43:e40–e46. - PubMed
-
- Koizumi M, Kuzume K, Ishida Y, et al. Serum thymus and activation-regulated chemokine (TARC) levels correlate with atopic dermatitis disease severity in patients < 6 months. Allergy Asthma Proc. 2022; 43:461-467. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
